Evaluation of radiation therapy for bone metastases: pain relief and quality of life.
The records of 158 patients irradiated for bone metastases were reviewed to evaluate the effectiveness of pain relief and to judge the effect of treatment on overall quality of life. Within 3 months 73% of the sites treated had pain relief, with 55%-65% having sustained relief up to 1 year or death. Of patients surviving more than 3 months, 63% maintained a satisfactory quality of life and were able to take care of most personal needs. The median survival of all patients was 1 year from initial treatment for bone metastasis. Radiation dose and the primary tumor site do not seem to be significant prognostic factors for initial pain relief or quality of life.
D001859:Bone Neoplasms / Q000532:radiotherapy*; D001943:Breast Neoplasms / Q000532:radiotherapy; D005264:Femoral Fractures / Q000209:etiology; D006801:Humans; D008175:Lung Neoplasms / Q000532:radiotherapy; D008297:Male; D009362:Neoplasm Metastasis; D010166:Palliative Care; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000532:radiotherapy; D011788:Quality of Life; D011878:Radiotherapy / Q000009:adverse effects; D013117:Spinal Cord Compression / Q000209:etiology